As illustrated in Fig. 8, based on clinical observations presented in Figs. 1 and 2, this study explored the molecular and cellular mechanisms by which ARRB2 was negatively implicated in lung cancer progression induced by TLR3 and TLR4 and proposed a possible model. Here, TLR3 is linked to lung carcinoma.